CIK 0000907654
- Non-accelerated filer
- Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363855489
- Phone
- +1 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $21,431,111
- in 18 filings, $21.0M under 10b5-1 plans
Net −$21,431,111. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
- Klein Lawrence Otto −$11.6M Chief Executive Officer sold 12% of stake
- Agarwal Arjun −$2.8M Senior Vice President, Finance sold 68% of stake
- Quinlan Paul T −$2.6M General Counsel sold 49% of stake
- Goncalves Joana −$2.0M Chief Medical Officer sold 41% of stake
- BALL KRISTINE M −$1.9M Director sold 100% of stake
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2005-01-07 | BENDEKGEY E LEE Sr VP CFO & General Counsel | Grant or award · Incentive Stock Option (right to buy) | +10,833 | 10,833 | ||
| 2004-12-30 | RATHMANN GEORGE B Director | Grant or award · Common Stock | +1,000 | 1,000 | ||
| 2004-12-29 | RATHMANN GEORGE B Director | Gift | −44,000 | $10.14 | $446K | 903,788 |
| 2004-11-30 | Titus Gary VP Finance, Chief Acct.Officer | Other acquisition | +136 | $7.69 | $1K | 379 |
| 2004-11-30 | RATHMANN GEORGE B Director | Grant or award · Non-Qualified Stock Option (right to buy) | +1,000 | 1,000 | ||
| 2004-11-23 | LEVY MICHAEL D Sr. VP Research & Development | Grant or award · Non-Qualified Stock Option (right to buy) | +134,312 | 134.31 | ||
| 2004-11-23 | LEVY MICHAEL D Sr. VP Research & Development | Grant or award · Incentive Stock Option (right to buy) | +40,688 | 40,688 | ||
| 2004-10-29 | RATHMANN GEORGE B Director | Grant or award · Non-Qualified Stock Option (right to buy) | +1,000 | 1,000 | ||
| 2004-09-30 | RATHMANN GEORGE B Director | Grant or award · Non-Qualified Stock Option (right to buy) | +1,000 | 1,000 | ||
| 2004-09-14 | RATHMANN GEORGE B Director | Grant or award · Non-Qualified Stock Option (right to buy) | +400,000 | 400,000 | ||
| 2004-09-14 | Titus Gary V.P. and Chief Acctg Officer | Grant or award · Non-Qualified Stock Option (right to buy) | +20,068 | 20,068 | ||
| 2004-09-14 | Titus Gary V.P. and Chief Acctg Officer | Grant or award · Incentive Stock Option (right to buy) | +19,932 | 19,932 | ||
| 2004-09-14 | SOBEL BURTON E Director | Grant or award · Non-Qualified Stock Option (right to buy) | +10,000 | 10,000 | ||
| 2004-08-31 | LOVE TED W President and C.E.O. | Other acquisition | +361 | $7.57 | $3K | 361 |
| 2004-08-31 | RATHMANN GEORGE B Director | Grant or award · Non-Qualified Stock Option (right to buy) | +1,000 | 1,000 | ||
| 2004-07-30 | CREDIT SUISSE FIRST BOSTON/ | Conversion | +18,218 | $4.98 | $91K | 188,667 |
| 2004-07-30 | CREDIT SUISSE FIRST BOSTON/ | Conversion | +209,364 | $4.98 | $1.0M | 1,215,554 |
| 2004-07-30 | CREDIT SUISSE FIRST BOSTON/ | Conversion | +12,562 | $4.98 | $63K | 130,088 |
| 2004-07-30 | CREDIT SUISSE FIRST BOSTON/ | Conversion | +698 | $4.98 | $3K | 7,230 |
| 2004-07-30 | CREDIT SUISSE FIRST BOSTON/ | Conversion · Warrants | −18,218 | 0 |
Page 38 of 41 · 802 trades